Issue 13, 2014

Bioanalysis of riluzole in human plasma by a sensitive LC-MS/MS method and its application to a pharmacokinetic study in South Indian subjects

Abstract

In this paper, the authors proposed a simple, rapid and highly sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method for the determination of riluzole in human plasma. Carbamazepine was used as an internal standard (IS). The method employed only 100 μL of human plasma for sample processing by a simple protein precipitation technique. The processed samples were chromatographed on a C18 column by using a mixture of 0.1% formic acid–acetonitrile (30 : 70, v/v) as the mobile phase at a flow rate of 0.9 mL min−1. The calibration curve obtained was linear over the concentration range of 0.10–500 ng mL−1 with r2 ≥ 0.99. Method validation was performed as per the FDA guidelines and the results met the acceptance criteria. The multiple reaction-monitoring mode (MRM) was used for quantification of ion transitions at m/z 235.0/165.9 and 237.2/194.1 for the analyte and the IS, respectively. A run time of 2.0 min for each sample made it possible to analyze more than 400 plasma samples per day, thus increasing the productivity. The validated method was successfully applied to a clinical pharmacokinetic study in South Indian male subjects under fasting conditions with a 50 mg riluzole tablet.

Graphical abstract: Bioanalysis of riluzole in human plasma by a sensitive LC-MS/MS method and its application to a pharmacokinetic study in South Indian subjects

Article information

Article type
Paper
Submitted
08 Mar 2014
Accepted
12 Apr 2014
First published
14 Apr 2014

Anal. Methods, 2014,6, 4823-4830

Author version available

Bioanalysis of riluzole in human plasma by a sensitive LC-MS/MS method and its application to a pharmacokinetic study in South Indian subjects

A. Narapusetti, S. S. Bethanabhatla, A. Sockalingam, N. R. Pilli, N. Repaka and T. Alla, Anal. Methods, 2014, 6, 4823 DOI: 10.1039/C4AY00583J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements